This inventor holds 2 USPTO granted patents. Top assignee: Synthelabo. Active years: 1997.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 1997
Title: The Innovations of Jean Jacques Koenig
Introduction
Jean Jacques Koenig is a notable inventor based in Maisons Laffitte, France. He has made significant contributions to the field of pharmaceuticals, holding a total of 2 patents. His work focuses on the development of novel compounds with therapeutic applications.
Latest Patents
Koenig's latest patents include N-[(1,4-diazabicyclo[2.2.2] oct-2-yl)methyl] benzamide derivatives, which are designed to enhance therapeutic efficacy. Additionally, he has developed oxazoloquinolinone derivatives, specifically 3,3a,4,5-Tetrahydro-1H-oxazolo[3,4-a]quinolin-1-one derivatives, which have potential therapeutic benefits.
Career Highlights
Throughout his career, Koenig has worked with Synthelabo, a company known for its innovative pharmaceutical solutions. His expertise in medicinal chemistry has led to advancements in drug development and therapeutic strategies.
Collaborations
Koenig has collaborated with esteemed colleagues such as Samir Jegham and Yves Guminski, contributing to a dynamic research environment that fosters innovation.
Conclusion
Jean Jacques Koenig's contributions to the field of pharmaceuticals through his patents and collaborations highlight his role as a significant inventor. His work continues to influence the development of new therapeutic compounds.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile